RealSleep offers a clinically-tested, cannabinoid-based product that lets users personalize a sleep formula by combining the company’s proprietary core blend with other natural compounds. The core formula features a proprietary blend of non-psychotropic cannabinoids, including CBD and CBN, intended to promote relaxation and restorative sleep. Users can opt for individualized formulas to suit personal sleep needs. The company raised $2.2M in seed funding and plans to use the proceeds to expand operations, accelerate growth and broaden its business reach. Leadership includes CEO Ashley Levine and co-founders Billy Gallagher and Michael Kamins. RealSleep is guided by a scientific advisory board that includes Dr. Christopher S. Colwell and Dr. Michael Ropacki.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Jul 2021